$168.08
0.130.08%
At close: Nov 13, 4:00 PM EST
$167.93
-0.15-0.09%
After Hours: Nov 13, 4:49 PM EST
Gilead Sciences Inc
GILDNASDAQ
The average analyst price target for Gilead Sciences is $150.79, 10.2% below the current price. Of 22 analysts, 18 rate it Buy and 4 Hold. Targets range from $80 to $200. The latest change came on Oct 30, 2026, when UBS raised its price target on Gilead Sciences from $175 to $195 and kept a Buy rating.
Price Target Range — 9 Quarters
Analyst Consensus — 22 Analysts
Rating Trend — Last 9 Months
